These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1243026)

  • 1. Antihypertensive action of indapamide. Comparative studies in several experimental models.
    Kyncl J; Oheim K; Seki T; Solles A
    Arzneimittelforschung; 1975 Oct; 25(10):1491-5. PubMed ID: 1243026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antihypertensive and diuretic effects of indapamide in normotensive and hypertensive rats (author's transl)].
    Morishita S; Nishimura K; Kato E; Shirahase H; Osumi S; Kitao K; Seki T
    Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):137-46. PubMed ID: 7084816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of the antihypertensive effect of indapamide by indomethacin.
    Pasnani JS; Gulati OD; Hemavathi KG
    Indian J Physiol Pharmacol; 1989; 33(3):146-50. PubMed ID: 2592038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indapamide treatment modifies the vascular reactivity of normotensive rat mesenteric arteries ex vivo.
    Tarkkila L; Paakkari I; Mervaala E; Nevala R; Vapaatalo H
    Methods Find Exp Clin Pharmacol; 1996; 18(1):5-11. PubMed ID: 8721250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacology and clinical pharmacology of indapamide.
    Campbell DB; Moore RA
    Postgrad Med J; 1981; 57 Suppl 2():7-17. PubMed ID: 7033951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive effect of the new calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats.
    Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
    Arzneimittelforschung; 1992 Jan; 42(1):9-16. PubMed ID: 1586389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antihypertensive action of indapamide in hypertension of chronic renal failure].
    Meyrier A; Condamin MC
    Ann Cardiol Angeiol (Paris); 1994 Jan; 43(1):43-8. PubMed ID: 8172477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of renal receptors for atrial natriuretic peptide and vasopressin in spontaneously hypertensive rats treated with antihypertensive diuretics.
    Ogura T; Nishida N; Watanabe H; Omiya T; Yamauchi T; Hosoya M; Hirata H; Kashihara N; Ota Z
    Res Commun Chem Pathol Pharmacol; 1994 Feb; 83(2):165-78. PubMed ID: 8202630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indapamide: clinical pharmacology, therapeutic efficacy in hypertension, and adverse effects.
    Mroczek WJ
    Pharmacotherapy; 1983; 3(2 Pt 1):61-7. PubMed ID: 6856486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of indapamide on an experimental model of cerebral ischemia in hypertensive rats.
    Delbarre B; Delbarre G
    Am J Med; 1988 Jan; 84(1B):20-5. PubMed ID: 3341387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combination of low doses of angiotensin-converting enzyme inhibitor and diuretics on renal function in spontaneously hypertensive rats: comparison between acute and chronic treatment.
    Doucet J; Richard V; Mulder P; Henry JP; Schiavi P; Guez D; Thuillez C
    J Renin Angiotensin Aldosterone Syst; 2001 Jun; 2(2):107-11. PubMed ID: 11881108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive effect of indapamide.
    Gragnoli G; Puccetti F; Nami R; Tanganelli I; Favilli R; Betti E
    Minerva Med; 1977 Mar; 68(12):749-60. PubMed ID: 846677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diuretic agents related to indapamide. IV--Synthesis and pharmacological activity of N-(4-chloro-3-sulfamoylbenzamido)-methyl-phenyl-pyrrolidines and N1-(4-chloro-3-sulfamoylbenzoyl)-N2-aryl- or aralkyl-alkyl-hydrazines.
    Cignarella G; Barlocco D; Landriani L; Pinna GA; Andriuoli G; Donà G
    Farmaco; 1991 Apr; 46(4):527-38. PubMed ID: 1930551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cicletanine with other antihypertensive drugs in SHR-SP models.
    Malherbe E; Le Hegarat M; Clostre F; Braquet P
    Drugs Exp Clin Res; 1988; 14(2-3):83-8. PubMed ID: 2970955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats.
    You D; Cochain C; Loinard C; Vilar J; Mees B; Duriez M; Lévy BI; Silvestre JS
    J Pharmacol Exp Ther; 2008 Jun; 325(3):766-73. PubMed ID: 18309090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of indapamide on muscle blood flow in hypertensive patients.
    Burgess CD; McKee CE; Wilson CA; Warren DJ
    Postgrad Med J; 1981; 57 Suppl 2():23-5. PubMed ID: 7322956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate.
    Germini M; Passoni A; Casciarri I; Bosetti P; Piazzoni L; Cazzulani P; Gandolfi CA; Tofanetti O; Ceserani R
    Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of treatment with low dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats.
    Rakusan K; Cicutti N; Maurin A; Guez D; Schiavi P
    Microvasc Res; 2000 Mar; 59(2):243-54. PubMed ID: 10684730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.